Chemomab Therapeutics Ltd.

CMMB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.38

-$0.10 (-4.03%)

At close: Sep 22, 2026, 4:00 PM ET

$2.49

+$0.11 (+4.62%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.03%

(1D)

Rating

Updated: Aug 29, 2026

21.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $14.65M

1D Range

2.36 2.63

52W Range

1.35 3.58

Valuation (TTM)

PE -2.43

PB 1.76

EV/EBITDA -1.08

Valuation (NTM)

Forward PE N/A

Forward PEG -0.05

Price Target N/A

Cash Flow

FCF Yield -73.5%

SBC Adj. FCF Yield -73.5%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 67.0% | 39.3%

FCF 3Y | 5Y 28.3% | 23.7%

Returns

ROA -74.3%

ROE -70.8%

ROIC -91.7%

Financial Health

Net Cash

$6.69M

Current Ratio 6.41

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions. Its leading experimental d...

Sector Healthcare

Industry Biotechnology

Employees 12

IPO Date Feb 11, 2019

Website www.chemomab.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.